Partners Calciphylaxis Biobank and Patient Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Calciphylaxis, a vascular calcification disorder, is a rare and serious disorder characterized by calcification of dermal arterioles. There are significant gaps in the understanding of the pathophysiology and risk factors for calciphylaxis. At present, there is no effective treatment. Uncertain pathobiology, rare incidence and lack of collaborative approach have been some of the major limiting factors towards treating calciphylaxis. The Partners Calciphylaxis Biorepository (PCB) aims to address these gaps within calciphylaxis research by utilizing existing and, when necessary, developing new infrastructure to support the consent of patients and the collection of dedicated samples for a calciphylaxis repository.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female ≥18 years old

• Skin lesions consistent with calciphylaxis diagnosis as determined by the treating clinician

• Informed of the investigational nature of the study and sign written Informed consent OR are eligible for surrogate consent process based on impaired decision making

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Sagar U Nigwekar, MD, MMSc
snigwekar@mgh.harvard.edu
617-726-7872
Time Frame
Start Date: 2017-01
Estimated Completion Date: 2030-12
Participants
Target number of participants: 300
Treatments
Study participants
No intervention
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov